Since the turn of the millennium, biotechnology has been undergoing a paradigm shift. While conventional medicine seeks to kill germs, relieve patients of symptoms, or remove failed organs, genomic medicine is seeking to identify health risks inherent in each individual's genetic make-up and intervene directly at that level. Likewise, while traditional organ transplantation endeavors to surpass organ failures under the scarcity of available organs that match, stem cell sciences are beginning to produce matching human tissues and use them to reverse the process of organ failures.
